The STEP trials published over the past year have established the efficacy and safety of semaglutide in treating patients with obesity. A new study analysing the […]
New research presented at this year’s European Congress on Obesity (held online, 10-13 May) shows that treatment with the drug semaglutide reduces body weight in adults […]
Following widespread vaccination against SARS-CoV-2 of older adults and other highly vulnerable groups, some high income countries are now considering vaccinating children; just days ago, the […]